Smith & Nephew plc (ADR) (NYSE:SNN)

CAPS Rating: 4 out of 5

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.

Recs

0
Player Avatar dreamjob (88.09) Submitted: 12/29/2012 8:02:26 PM : Outperform Start Price: $53.65 SNN Score: +2.63

Management at SNN has achieved very strong ROIC and Cash ROIC numbers. Sales, earnings, and book value are all growing at a healthy clip. There are positive, stable, and growing owner earnings and free cash flow. There is also manageable debt here. I believe this is priced slightly below intrinsic value. I also like that this has recently become a 5 Star CAPS stock.

Featured Broker Partners


Advertisement